. Author manuscript; available in PMC: 2014 Oct 10.

Published in final edited form as: J Blood Disord Transfus. 2013 Sep 20;4(5):158. doi: 10.4172/2155-9864.1000158

Table 3.

MANOVA showing no significant influence of cryopreservation for 7 days −80°C and type of medium (Gibco or the custom medium) on cell subsets EPC-EC (double or triple positive subsets expressed as percentage in live PBMC).

PBMC phenotype	Type of medium	Temperature

CD34+CD133+VEGFR2−	F_{2, 9}=0.42, p=0.6714	F_{1, 7}=0.07, p=0.7946
CD34+CD133−VEGFR2+	F_{2, 9}=0.49, p=0.6280	F_{1, 7}=0.87, p=0.3831
CD146+CD34+VEGFR2−	F_{2, 9}=0.91, p=0.4367	F_{1, 7}=1.40, p=0.2746
CD146+CD34+VEGFR2+	F_{2, 9}=0.49, p=0.6280	F_{1, 7}=1.05, p=0.3394
CD146+CD34−VEGFR2+	F_{2, 9}=1.61, p=0.2521	F_{1, 7}=1.55, p=0.2533